TABLE OF CONTENTS I
LIST OF FIGURES XVI
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
CHINA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
MARKETS INCLUDED 7
KEY REPORT UPDATES 8
VERSION HISTORY 8
RESEARCH METHODOLOGY 9
1.1 RESEARCH SCOPE 9
1.2 IDATA’S 9-STEP METHODOLOGY 9
1.2.1 Step 1: Project Initiation & Team Selection 9
1.2.2 Step 2: Prepare Data Systems and Perform Secondary Research 11
1.2.3 Step 3: Preparation for Interviews & Questionnaire Design 12
1.2.4 Step 4: Performing Primary Research 13
1.2.5 Step 5: Research Analysis: Establishing Baseline Estimates 15
1.2.6 Step 6: Market Forecast and Analysis 16
1.2.7 Step 7: Identify Strategic Opportunities 18
1.2.8 Step 8: Final Review and Market Release 19
1.2.9 Step 9: Customer Feedback and Market Monitoring 20
DISEASE OVERVIEW 21
2.1 BASIC ANATOMY 21
2.1.1 Human Vascular System 21
2.2 VASCULAR PATHOLOGY AND DISORDERS 22
2.2.1 Cancer 22
2.2.2 End-Stage Renal Disease 23
2.2.3 Diabetes 25
PRODUCT ASSESSMENT 28
3.1 PRODUCT PORTFOLIOS 28
3.1.1 Dialysis Catheters 28
3.1.1.1 Introduction 28
3.1.1.1.1 AV Fistulae 29
3.1.1.1.2 AV Grafts 29
3.1.1.1.3 Dialysis Catheters 30
3.1.1.2 AngioDynamics 32
3.1.1.2.1 DuraMax® 32
3.1.1.2.2 DuraFlow™ 32
3.1.1.2.3 Schon™ 32
3.1.1.2.4 Other Dialysis Catheter Offerings 32
3.1.1.3 Argon Medical 32
3.1.1.3.1 UltraStream™ 32
3.1.1.4 Baxter 33
3.1.1.4.1 GamCath™ 33
3.1.1.5 Cook Medical 33
3.1.1.5.1 Turbo-Flo® 33
3.1.1.5.2 Tenckhoff™ 33
3.1.1.6 C.R. Bard 33
3.1.1.6.1 EQUISTREAM® 33
3.1.1.6.2 HemoSplit® 33
3.1.1.6.3 HemoStar® 34
3.1.1.6.4 Niagara™ 34
3.1.1.6.5 Other Dialysis Catheter Offerings 34
3.1.1.7 Marvao Medical 34
3.1.1.7.1 NexSite™ 34
3.1.1.8 Medcomp 34
3.1.1.8.1 Split Cath® 34
3.1.1.8.2 Hemo-Cath® 35
3.1.1.8.3 Hemo-Flow® 35
3.1.1.8.4 Other Dialysis Catheter Offerings 35
3.1.1.9 Medtronic 35
3.1.1.9.1 MAHURKAR™ 35
3.1.1.9.2 Palindrome™ 35
3.1.1.9.3 Other Dialysis Catheter Offerings 36
3.1.1.10 Merit Medical 36
3.1.1.10.1 Flex-Neck® 36
3.1.1.10.2 Centros™ 36
3.1.1.10.3 ProGuide™ 36
3.1.1.11 PFM Medical 36
3.1.1.11.1 Veta™ 36
3.1.1.12 Phase One Medical 36
3.1.1.12.1 Symetrex™ 36
3.1.1.13 Teleflex Medical 37
3.1.1.13.1 NextStep® 37
3.1.1.13.2 VectorFlow™ 37
3.1.1.13.3 Other Dialysis Catheter Offerings 37
3.2 REGULATORY ISSUES AND RECALLS 38
3.2.1 November 2015 38
3.2.2 October 2015 38
3.2.3 September 2015 39
3.2.4 August 2015 41
3.2.5 July 2015 42
3.2.6 April 2015 44
3.2.7 March 2015 45
3.2.8 February 2015 46
3.2.9 January 2015 46
3.2.10 December 2014 47
3.2.11 October 2014 48
3.2.12 September 2014 49
3.2.13 May 2014 50
3.2.14 April 2014 50
3.2.15 March 2014 51
3.2.16 January 2014 51
3.2.17 December 2013 52
3.2.18 September 2013 53
3.2.19 August 2013 54
3.2.20 June 2013 54
3.2.21 March 2013 55
3.2.22 February 2013 56
3.2.23 December 2012 56
3.2.24 August 2012 56
3.2.25 June 2012 57
3.2.26 May 2012 58
3.2.27 March 2012 59
3.2.28 February 2012 60
3.2.29 January 2012 60
3.3 CLINICAL TRIALS 64
3.3.1 Dialysis Catheters 65
3.4 PRODUCT PIPELINES 71
3.4.1 Alliance Vascular Devices, LLC 71
3.4.1.1 FreeHand Safety Huber Needle® 71
3.4.2 AngioDynamics 71
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation 71
3.4.2.2 Firefly 71
3.4.2.3 BioFlo® PICC Line Extension 72
3.4.2.4 BioFlo® Port Line Extension 72
3.4.2.5 Next Generation BioFlo® PICC 72
3.4.2.6 Next Generation BioFlo® Port 72
3.4.3 Bluegrass Vascular Technologies, Inc. 72
3.4.3.1 Surfacer® Inside-Out™ Access System 72
3.4.4 C.R. Bard 72
3.4.4.1 Chemical-Resistant PICCs 72
3.4.4.2 Novel Advanced Material PICCs 73
3.4.4.3 PowerGlide® Pro Midline 73
3.4.4.4 AccuCath® 73
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter 73
3.4.4.6 Site~Rite® 8 Ultrasound System 73
3.4.5 M. C. Johnson 73
3.4.5.1 PICC Securement Device 73
3.4.6 Nipro Medical 74
3.4.6.1 Shielding Safety Needle 74
3.4.6.2 Safety Syringe 74
3.4.6.3 Safety PIVC 74
3.4.7 Parasol Medical 74
3.4.7.1 Catheter Securement Device 74
3.4.8 PAVmed Inc. 74
3.4.8.1 NextCath™ 74
3.4.9 Phase One Medical 74
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter 74
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter 75
3.4.10 Prodigy Diabetes Care, LLC. 75
3.4.10.1 Insulin Pen Needles 75
3.4.11 Sharklet Technologies, Inc. 75
3.4.11.1 Sharklet™ Central Venous Catheter 75
3.4.12 Starboard Medical 75
3.4.12.1 Catheter Securement Devices 75
3.4.13 Teleflex Medical 76
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System 76
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports 76
3.4.14 Vascular Access Technologies, Inc. 76
3.4.14.1 SAFECVAD™ 76
DIALYSIS CATHETER MARKET 77
4.1 MARKET ANALYSIS AND FORECAST 77
4.2 DRIVERS AND LIMITERS 80
4.2.1 Market Drivers 80
4.2.2 Market Limiters 81
4.3 COMPETITIVE MARKET SHARE ANALYSIS 83
ABBREVIATIONS 86
APPENDIX: COMPANY PRESS RELEASES 87

The "China Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite" includes analysis on the following companies currently active in this market:
CR Bard
Teleflex
BD
B Braun
Smiths Medical
Medtronic
Cook Medical
Others include: Changzhou Yuandong Medical, Henan Concerone Industry Co., Heze Sinorgmed Polymers Co., Jiangsu Province Huaxing Medical, Jiangxi Sanxin Medtec Co., Lepu Medical Technology, Longreal Medevice Limited, Melson Medical Corporation Limited, Nanjing Hoshin Medical Instrument Co., Ningbo Win-Win Medical Instruments, Poweam Medical, Qingdao Joyjun Medical Products Co, Qingdao Medical Import & Export Co., Shandong Sinorgmed Co., Ltd., Shanghai Hengxin Medical Devices, Shanghai Madicare Co., Zibo Eastmed Healthcare Products, etc
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Chart 1 1: Vascular Access Device and Accessories Market by Segment China, 2013 – 2023 2
Chart 1 2: Vascular Access Device and Accessories Market China, 2016 & 2023 2
Chart 4 1: Total Dialysis Catheter Market, China, 2013 – 2023 79
Chart 4 2: Leading Competitors, Dialysis Catheter Market, China, 2016 85

Figure 1 1: Leading Competitors by Segment, Vascular Access Device and Accessories Market, China, 2016 (1 of 2) 3
Figure 1 2: Leading Competitors by Segment, Vascular Access Device and Accessories Market, China, 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, China, 2016 4
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market, China 5
Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, China, 2012 – 2016 6
Figure 1 6: Vascular Access Device and Accessories Markets Covered, China, 2016 7
Figure 1 7: Key Report Updates 8
Figure 1 8: Version History 8
Figure 3 1: Class 2 Device Recall Medtronic 38
Figure 3 2: Class 2 Device Recall Smiths Medical 38
Figure 3 3: Class 2 Device Recall Arrow 39
Figure 3 4: Class 2 Device Recall Arrow 39
Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 40
Figure 3 6: Class 2 Device Recall Arrow 41
Figure 3 7: Class 2 Device Recall Medline 41
Figure 3 8: Class 2 Device Recall Arrow 41
Figure 3 9: Class 2 Device Recall B. Braun 41
Figure 3 10: Class 3 Device Recall Bard Access 42
Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 42
Figure 3 12: Class 2 Device Recall Bard Access 44
Figure 3 13: Class 2 Device Recall Bard Access 44
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 45
Figure 3 15: Class 2 Device Recall Bard Access 45
Figure 3 16: Class 2 Device Recall Arrow 46
Figure 3 17: Class 2 Device Recall Medcomp 46
Figure 3 18: Class 2 Device Recall Arrow 46
Figure 3 19: Class 2 Device Recall Arrow 47
Figure 3 20: Class 2 Device Recall Smiths Medical 47
Figure 3 21: Class 2 Device Recall PFM Medical 47
Figure 3 22: Class 2 Device Recall PFM Medical 47
Figure 3 23: Class 2 Device Recall Becton Dickinson 48
Figure 3 24: Class 2 Device Recall Arrow 48
Figure 3 25: Class 2 Device Recall Arrow 48
Figure 3 26: Class 2 Device Recall Navilyst Medical 48
Figure 3 27: Class 2 Device Recall Argon Medical 49
Figure 3 28: Class 2 Device Recall Arrow 50
Figure 3 29: Class 2 Device Recall Arrow 50
Figure 3 30: Class 2 Device Recall Arrow 51
Figure 3 31: Class 2 Device Recall Bard Access 51
Figure 3 32: Class 2 Device Recall Navilyst Medical 51
Figure 3 33: Class 2 Device Recall Bard Access 52
Figure 3 34: Class 2 Device Recall Smiths Medical 52
Figure 3 35: Class 2 Device Recall B. Braun 52
Figure 3 36: Class 2 Device Recall Smiths Medical 53
Figure 3 37: Class 2 Device Recall Access Scientific 53
Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 53
Figure 3 39: Class 2 Device Recall Arrow 54
Figure 3 40: Class 2 Device Recall Bard Access 54
Figure 3 41: Class 2 Device Recall Becton Dickinson 54
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 55
Figure 3 43: Class 2 Device Recall Bard Access 55
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 55
Figure 3 45: Class 2 Device Recall Medcomp 56
Figure 3 46: Class 2 Device Recall Becton Dickinson 56
Figure 3 47: Class 3 Device Recall Bard Access 56
Figure 3 48: Class 2 Device Recall Medcomp 57
Figure 3 49: Class 1 Device Recall Arrow 57
Figure 3 50: Class 2 Device Recall Arrow 57
Figure 3 51: Class 2 Device Recall Vygon 57
Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 58
Figure 3 53: Class 2 Device Recall Medcomp 59
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 59
Figure 3 55: Class 2 Device Recall Christie Medical Holdings 59
Figure 3 56: Class 3 Recall Bard Access 59
Figure 3 57: Class 2 Device Recall AngioDynamics 60
Figure 3 58: Class 2 Device Recall Becton Dickinson 60
Figure 3 59: Class 2 Device Recall AngioDynamics 60
Figure 3 60: Class 2 Device Recall AngioDynamics 62
Figure 3 61: Class 3 Device Recall AngioDynamics 63
Figure 3 62: Class 2 Device Recall AngioDynamics 63
Figure 3 63: ACCESS HD Pilot 65
Figure 3 64: Randomized Controlled Trial of Straight Versus Coiled Peritoneal Dialysis 66
Figure 3 65: Randomized Trial Comparing VectorFlow™ Tunneled Dialysis Catheter 66
Figure 3 66: Duration and Adverse Events of Non-cuffed Catheter 66
Figure 3 67: Vascular Access Choice and Outcomes in the Elderly and Very Elderly 67
Figure 3 68: Prevention of Tunneled Cuffed Catheter Malfunction 67
Figure 3 69: Analysis of CRBSI 68
Figure 3 70: A Prospective Multicenter Investigation 68
Figure 3 71: Comparison of an Intensive Versus a Standard Hemodialysis Central Venous Catheter 68
Figure 3 72: Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter for Dialysis 69
Figure 3 73: Comparison of Self-locating Catheter Versus a Straight Catheter for Outflow Problems 69
Figure 3 74: Multi-Center, Prospective, Randomized, Open-Label, Sponsor-Blinded, Active-Control (Heparin) Clinical Investigation 70
Figure 3 75: Comparative Effectiveness of 30% Trisodium Citrate and Heparin Lock Solutions 70
Figure 4 1: Total Dialysis Catheter Market, China, 2013 – 2023 78
Figure 4 2: Drivers and Limiters, Dialysis Catheter Market, China, 2016 82
Figure 4 3: Leading Competitors, Dialysis Catheter Market, China, 2016 84
Figure 6 1: Press Release Summary 87

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

• Original primary research that consists of the most up-to-date market data
• Strong foundation of quantitative and qualitative research
• Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology